ATRA promotes granulocytic differentiation restoring transcriptional activation of RARA target genes that are involved in cellular differentiation and by PML‐RARα degradation, but the isolated therapy with ATRA leads to transient remission of disease [26], suggesting involvement of other mechanisms in the self‐renewal of APL cells. The gene discussed is RARA; the disease is acute promyelocytic leukemia.